Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies

BACKGROUND: Anxiety and depression (A/D) are common in patients with chronic obstructive pulmonary disease (COPD) and are often associated with lower adherence to treatment and worse patient-related outcomes. However, studies on the impact of comorbid A/D on responses to bronchodilators are limited....

Descripción completa

Detalles Bibliográficos
Autores principales: Hanania, Nicola A, Yohannes, Abebaw M, Ozol-Godfrey, Ayca, Tocco, Michael, Goodin, Thomas, Sharma, Sanjay, Sanjar, Shahin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020329/
https://www.ncbi.nlm.nih.gov/pubmed/33833507
http://dx.doi.org/10.2147/COPD.S294053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020329/
https://www.ncbi.nlm.nih.gov/pubmed/33833507
http://dx.doi.org/10.2147/COPD.S294053

Ejemplares similares